Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse

feature-image

Play all audios:

Loading...

ABSTRACT Approximately 50% of patients with early-stage non-small-cell lung cancer (NSCLC) who undergo surgery with curative intent will relapse within 5 years1,2. Detection of circulating


tumor cells (CTCs) at the time of surgery may represent a tool to identify patients at higher risk of recurrence for whom more frequent monitoring is advised. Here we asked whether


CellSearch-detected pulmonary venous CTCs (PV-CTCs) at surgical resection of early-stage NSCLC represent subclones responsible for subsequent disease relapse. PV-CTCs were detected in 48% of


100 patients enrolled into the TRACERx study3, were associated with lung-cancer-specific relapse and remained an independent predictor of relapse in multivariate analysis adjusted for tumor


stage. In a case study, genomic profiling of single PV-CTCs collected at surgery revealed higher mutation overlap with metastasis detected 10 months later (91%) than with the primary tumor


(79%), suggesting that early-disseminating PV-CTCs were responsible for disease relapse. Together, PV-CTC enumeration and genomic profiling highlight the potential of PV-CTCs as early


predictors of NSCLC recurrence after surgery. However, the limited sensitivity of PV-CTCs in predicting relapse suggests that further studies using a larger, independent cohort are warranted


to confirm and better define the potential clinical utility of PV-CTCs in early-stage NSCLC. Access through your institution Buy or subscribe This is a preview of subscription content,


access via your institution ACCESS OPTIONS Access through your institution Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99


/ 30 days cancel any time Learn more Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on


SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about


institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS CIRCULATING TUMOUR DNA IN EARLY STAGE AND LOCALLY ADVANCED NSCLC: READY FOR


CLINICAL IMPLEMENTATION? Article 20 January 2025 PLASTICITY OF CIRCULATING TUMOR CELLS IN SMALL CELL LUNG CANCER Article Open access 21 July 2023 GENOMIC CHARACTERISTICS AND CLINICAL


SIGNIFICANCE OF CD56+ CIRCULATING TUMOR CELLS IN SMALL CELL LUNG CANCER Article Open access 03 March 2023 DATA AVAILABILITY Most data generated or analyzed during this study are included in


this published article. The sequencing data are available through the Cancer Research UK & University College London Cancer Trials Centre for non-commercial research purposes. Access


will be granted upon review of a project proposal that will be evaluated by a TRACERx data access committee, and an appropriate data access agreement will be entered into, subject to any


applicable ethical approvals. CHANGE HISTORY * _ 03 JUNE 2020 An amendment to this paper has been published and can be accessed via a link at the top of the paper. _ REFERENCES * Uramoto, H.


& Tanaka, F. Recurrence after surgery in patients with NSCLC. _Transl. Lung Cancer Res._ 3, 242–249 (2014). PubMed  PubMed Central  Google Scholar  * Taylor, M. D. et al. Tumor


recurrence after complete resection for non-small cell lung cancer. _Ann. Thorac. Surg._ 93, 1813–1820 (2012). Article  Google Scholar  * Jamal-Hanjani, M. et al. Tracking the evolution of


non-small-cell lung cancer. _N Engl J Med_. 376, 2109–2121 (2017). * Siegel, R. L., Miller, K. D. & Jemal, A. Cancer Statistics, 2017. _CA Cancer J. Clin._ 67, 7–30 (2017). Article 


Google Scholar  * Aceto, N., Toner, M., Maheswaran, S. & Haber, D. A. En route to metastasis: circulating tumor cell clusters and epithelial-to-mesenchymal transition. _Trends Cancer_ 1,


44–52 (2015). Article  Google Scholar  * Hodgkinson, C. et al. Circulating tumour cells from small cell lung cancer patients are tumourigenic. _Lung Cancer_ 87, S1 (2015). Article  Google


Scholar  * Morrow, C. J. et al. Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study. _Ann. Oncol._ 27, 1155–1160 (2016). Article  CAS  Google


Scholar  * Baccelli, I. et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. _Nat. Biotechnol._


31, 539–544 (2013). Article  CAS  Google Scholar  * Girotti, M. R. et al. Application of sequencing, liquid biopsies, and patient-derived xenografts for personalized medicine in melanoma.


_Cancer Discov._ 6, 286–299 (2016). Article  CAS  Google Scholar  * Mohan, S., Chemi, F. & Brady, G. Challenges and unanswered questions for the next decade of circulating tumour cell


research in lung cancer. _Transl. Lung Cancer Res._ 6, 454–472 (2017). Article  CAS  Google Scholar  * Crosbie, P. A. et al. Circulating tumor cells detected in the tumor-draining pulmonary


vein are associated with disease recurrence after surgical resection of NSCLC. _J. Thorac. Oncol._ 11, 1793–1797 (2016). Article  Google Scholar  * Jamal-Hanjani, M. et al. Tracking genomic


cancer evolution for precision medicine: the lung TRACERx study. _PLoS Biol._ 12, e1001906 (2014). * Abbosh, C. et al. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.


_Nature_ 545, 446 (2017). Article  CAS  Google Scholar  * Romero-Palacios, P. J. et al. Liquid biopsy beyond of cancer: circulating pulmonary cells as biomarkers of COPD aggressivity. _Crit.


Rev. Oncol. Hematol._ 136, 31–36 (2019). Article  Google Scholar  * Deleye, L., Vander Plaetsen, A. S., Weymaere, J., Deforce, D. & Van Nieuwerburgh, F. Short tandem repeat analysis


after whole genome amplification of single B-lymphoblastoid cells. _Sci. Rep._ 8, 1255 (2018). Article  Google Scholar  * Lin, C. W. et al. MicroRNA-135b promotes lung cancer metastasis by


regulating multiple targets in the Hippo pathway and LZTS1. _Nat. Commun._ 4, 1877 (2013). Article  Google Scholar  * Heitzer, E. et al. Complex tumor genomes inferred from single


circulating tumor cells by array-CGH and next-generation sequencing. _Cancer Res._ 73, 2965 (2013). Article  CAS  Google Scholar  * Lohr, J. G. et al. Whole-exome sequencing of circulating


tumor cells provides a window into metastatic prostate cancer. _Nat. Biotechnol._ 32, 479–484 (2014). Article  CAS  Google Scholar  * Gill, R. & Schumacher, M. A simple test of the


proportional hazards assumption. _Biometrika_ 74, 289–300 (1987). Article  Google Scholar  * Therneau, T. M., Grambsch, P. M. & Fleming, T. R. Martingale-based residuals for survival


models. _Biometrika_ 77, 147–160 (1990). Article  Google Scholar  * Altman, D. G., McShane, L. M., Sauerbrei, W. & Taube, S. E. Reporting Recommendations for Tumor Marker Prognostic


Studies (REMARK): explanation and elaboration. _PLoS Med._ 9, e1001216 (2012). Article  Google Scholar  * R Code Team. _R: A Language and Environment for Statistical Computing_. (R


Foundation for Statistical Computing, 2013). * Therneau, T. A package for survival analysis in S v 2.38 (2015). * Kassambara, A., Kosinski, M. & Biecek, P. survminer: Drawing Survival


Curves using’ggplot2’. _R package version 0.3_ 1 (2017). * Heagerty, P. J. & Zheng, Y. Survival model predictive accuracy and ROC curves. _Biometrics_ 61, 92–105 (2005). Article  Google


Scholar  * Mesquita, B. et al. Molecular analysis of single circulating tumour cells following long-term storage of clinical samples. _Mol. Oncol._ 11, 1687–1697 (2017). Article  CAS  Google


Scholar  * Rothwell, D. G. et al. Genetic profiling of tumours using both circulating free DNA and circulating tumour cells isolated from the same preserved whole blood sample. _Mol.


Oncol._ 10, 566–574 (2016). Article  CAS  Google Scholar  * Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. _B__ioinformatics_ 25, 1754–1760


(2009). CAS  Google Scholar  * Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. _Bioinformatics_ 26, 841–842 (2010). Article  CAS 


Google Scholar  * Andrews, S. FastQC: a quality control tool for high throughput sequence data. http://www.bioinformatics.babraham.ac.uk/projects/fastqc (2010). * Cibulskis, K. et al.


Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. _Nat Biotechnol_. 31, 213–219 (2013). * Ha, G. et al. Integrative analysis of genome-wide loss of


heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer. _Genome Res._ 22, 1995–2007 (2012). Article  CAS  Google


Scholar  * Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. _Nucleic Acids Res._ 38, e164 (2010). Article 


Google Scholar  * Tamborero, D. et al. Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations. _Genome Med._ 10, 25 (2018). Article  Google Scholar 


Download references ACKNOWLEDGEMENTS We sincerely thank the patients and their families for donating blood samples for research. We thank E. Aidaros-Talbot for administrative assistance with


the manuscript. We also thank J. Shaw for kindly providing plasma (relapse time point) of patient CRUK0242. TRACERx is funded by Cancer Research UK (grant C11496/A17786). This research was


supported by Cancer Research UK–Core funding to the CRUK Manchester Institute (C5759/A27412) Centre, funding to the CRUK Manchester Centre (C5759/A25254) and funding of the CRUK Lung Cancer


Centre of Excellence. Support was also received from the Manchester Experimental Cancer Medicine Centre and Manchester NIHR Biomedical Research Centre. F.C. is funded by the CANCER-ID


Consortium (115749-Cancer-ID). B.M. is funded by Menarini Biomarkers Singapore PTE Ltd. C.S.K. is funded by The Manchester MRC Single Cell Research Centre (MR/M008908/1). C.S. is Royal


Society Napier Research Professor. This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001169, FC001202), the UK Medical


Research Council (FC001169, FC001202) and the Wellcome Trust (FC001169, FC001202). C.S. is funded by Cancer Research UK (TRACERx and CRUK Cancer Immunotherapy Catalyst Network), the CRUK


Lung Cancer Centre of Excellence, Stand Up 2 Cancer (SU2C), the Rosetrees Trust, the Butterfield and Stoneygate Trusts, NovoNordisk Foundation (ID16584), the Prostate Cancer Foundation and


the Breast Cancer Research Foundation (BCRF). The research leading to these results has received funding from the European Research Council (ERC) under the European Union’s Seventh Framework


Programme (FP7/2007-2013) Consolidator Grant (FP7-THESEUS-617844), European Commission ITN (FP7-PloidyNet 607722), an ERC Advanced Grant (PROTEUS) from the European Research Council under


the European Union’s Horizon 2020 research and innovation programme (grant agreement 835297). Support was also provided to C.S. by the National Institute for Health Research, the University


College London Hospitals Biomedical Research Centre and the Cancer Research UK University College London Experimental Cancer Medicine Centre. AUTHOR INFORMATION Author notes * These authors


contributed equally: Francesca Chemi, Dominic G. Rothwell, Nicholas McGranahan. * A list of members and affiliations appears online. AUTHORS AND AFFILIATIONS * Clinical and Experimental


Pharmacology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK Francesca Chemi, Dominic G. Rothwell, Sakshi Gulati, Simon P. Pearce, Cong Zhou, 


Jackie Pierce, Chang Sik Kim, Saba Ferdous, Deborah J. Burt, Daniel Slane-Tan, Barbara Mesquita, Jonathan Tugwood, Ged Brady, Caroline Dive, Jonathan Tugwood, Jackie Pierce, Dominic G.


Rothwell, Caroline Dive, Ged Brady & Francesca Chemi * Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK Francesca Chemi, Fabio Gomes, 


Philip Crosbie, Fiona Blackhall, Ged Brady, Caroline Dive, Caroline Dive, Ged Brady, Francesca Chemi, Fabio Gomes, Fiona Blackhall, Philip Crosbie, Elaine Kilgour, Lynsey Priest & 


Matthew G. Krebs * Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK Nicholas McGranahan, Mariam Jamal-Hanjani, Crispin Hiley, 


Charles Swanton, Charles Swanton, Mariam Jamal-Hanjani, Crispin Hiley & Nicholas McGranahan * University College London Cancer Institute, London, UK Nicholas McGranahan, Chris Abbosh, 


Gareth A. Wilson, Mariam Jamal-Hanjani, Nicolai Birkbak, David Moore, Crispin Hiley, Selvaraju Veeriah, Allan Hackshaw, Charles Swanton, Charles Swanton, Mariam Jamal-Hanjani, Crispin Hiley,


 Nicholas McGranahan, Allan Hackshaw, Chris Abbosh, Selvaraju Veeriah, David Moore, Gareth A. Wilson, Nicolai Birkbak, Yin Wu, Marcin Skrzypski, Robert E. Hynds, Andrew Georgiou, Mariana


Werner Sunderland, James L. Reading, Sergio A. Quezada, Karl S. Peggs, Teresa Marafioti, John A. Hartley, Pat Gorman, Helen L. Lowe, Leah Ensell, Victoria Spanswick, Angeliki Karamani, 


Maryam Razaq, Stephan Beck, Ariana Huebner, Michelle Dietzen, Cristina Naceur-Lombardelli, Mita Afroza Akther, Haoran Zhai, Nnennaya Kannu, Elizabeth Manzano, Supreet Kaur Bola, Ehsan


Ghorani, Marc Robert de Massy, Elena Hoxha, Emine Hatipoglu, Stephanie Ogwuru & Benny Chain * Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK


Nicholas McGranahan, Gareth A. Wilson, Nicolai Birkbak, Maise Al Bakir, Sophia Ward, Dhruva Biswas, Charles Swanton, Charles Swanton, Nicholas McGranahan, Gareth A. Wilson, Nicolai Birkbak, 


Sophia Ward, Maise Al Bakir & Dhruva Biswas * Department of Molecular Medicine, Aarhus University, Aarhus, Denmark Nicolai Birkbak & Nicolai Birkbak * Department of Thoracic Surgery,


Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK Rajesh Shah & Rajesh Shah * Division of Cancer Sciences, Faculty of Biology Medicine and Health,


University of Manchester, Manchester, UK Yvonne Summers, Philip Crosbie, Fiona Blackhall, Fiona Blackhall, Philip Crosbie & Yvonne Summers * North West Lung Centre, Wythenshawe Hospital,


Manchester University NHS Foundation Trust, Manchester, UK Philip Crosbie & Philip Crosbie * Scientific Computing Core Facility, Cancer Research UK Manchester Institute, The University


of Manchester, Alderley Park, UK Marek Dynowski * RNA Biology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK Crispin Miller * Cancer Research UK


& UCL Cancer Trials Centre, London, UK Yenting Ngai, Abigail Sharp, Cristina Rodrigues, Oliver Pressey, Sean Smith, Nicole Gower & Harjot Dhanda * Cancer Research UK Manchester


Institute, University of Manchester, Manchester, UK Elaine Kilgour * Christie NHS Foundation Trust, Manchester, UK Lynsey Priest, Matthew G. Krebs, Mathew Carter & Colin R. Lindsay * The


Francis Crick Institute, London, UK Thomas B. K. Watkins, Rachel Rosenthal, Mickael Escudero, Aengus Stewart, Andrew Rowan, Jacki Goldman, Peter Van Loo, Richard Kevin Stone, Tamara Denner,


 Emma Nye, Emilia Lim, Stefan Boeing, Maria Greco, Kevin Litchfield, Jerome Nicod, Clare Puttick, Katey Enfield, Emma Colliver & Brittany Campbell * Wythenshawe Hospital, Manchester


University NHS Foundation Trust, Manchester, UK Raffaele Califano, Paul Taylor, Piotr Krysiak, Kendadai Rammohan, Eustace Fontaine, Richard Booton, Matthew Evison, Stuart Moss, Juliette


Novasio, Leena Joseph, Paul Bishop, Anshuman Chaturvedi, Helen Doran, Felice Granato, Vijay Joshi, Elaine Smith & Angeles Montero * Aberdeen Royal Infirmary, Aberdeen, UK Gillian Price, 


Sylvie Dubois-Marshall, Keith Kerr, Shirley Palmer, Heather Cheyne, Joy Miller, Keith Buchan, Mahendran Chetty & Mohammed Khalil * Ashford and St Peter’s Hospitals NHS Foundation Trust,


Chertsey, UK Veni Ezhil & Vineet Prakash * Barnet Hospital and Chase Farm Hospital, London, UK Girija Anand & Sajid Khan * Barts Health NHS Trust, London, UK Kelvin Lau, Michael


Sheaff, Peter Schmid, Louise Lim & John Conibear * Berlin Institute for Medical Systems Biology, Max Delbrueck Center for Molecular Medicine, Berlin, Germany Roland Schwarz * German


Cancer Consortium (DKTK), partner site Berlin, Berlin, Germany Roland Schwarz * German Cancer Research Center (DKFZ), Heidelberg, Germany Roland Schwarz * Cancer Research Centre, University


of Leicester, Leicester, UK John Le Quesne, Joan Riley, Lindsay Primrose, Luke Martinson, Nicolas Carey, Jacqui A. Shaw & Dean Fennell * Leicester University Hospitals, Leicester, UK


Dean Fennell, Apostolos Nakas, Sridhar Rathinam, Louise Nelson, Kim Ryanna, Mohamad Tuffail, Amrita Bajaj & Jan Brozik * Cardiff & Vale University Health Board, Cardiff, UK Fiona


Morgan, Malgorzata Kornaszewska, Richard Attanoos, Haydn Adams & Helen Davies * Danish Cancer Society Research Center, Copenhagen, Denmark Zoltan Szallasi * Department of Pathology,


GZA-ZNA Antwerp, Antwerp, Belgium Roberto Salgado * Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Budapest, Hungary Istvan Csabai & Miklos Diossy * Departments


of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA Hugo Aerts * Department of Radiology, Netherlands


Cancer Institute, Amsterdam, The Netherlands Hugo Aerts * Golden Jubilee National Hospital, Clydebank, UK Alan Kirk, Mo Asif, John Butler, Rocco Bilanca & Nikos Kostoulas * Independent


Cancer Patients’ Voice, London, UK Mairead MacKenzie & Maggie Wilcox * University of Leicester, Leicester, UK Sara Busacca, Alan Dawson & Mark R. Lovett * Liverpool Heart and Chest


Hospital NHS Foundation Trust, Liverpool, UK Michael Shackcloth, Sarah Feeney & Julius Asante-Siaw * Royal Liverpool University Hospital, Liverpool, UK John Gosney * Manchester Cancer


Research Centre Biobank, Manchester, UK Angela Leek, Nicola Totten, Jack Davies Hodgkinson, Rachael Waddington, Jane Rogan & Katrina Moore * National Institute for Health Research


Leicester Respiratory Biomedical Research Unit, Leicester, UK William Monteiro & Hilary Marshall * NHS Greater Glasgow and Clyde, Glasgow, UK Kevin G. Blyth, Craig Dick & Andrew Kidd


* Royal Brompton and Harefield NHS Foundation Trust, London, UK Eric Lim, Paulo De Sousa, Simon Jordan, Alexandra Rice, Hilgardt Raubenheimer, Harshil Bhayani, Morag Hamilton, Lyn Ambrose, 


Anand Devaraj, Hema Chavan, Sofina Begum, Aleksander Mani, Daniel Kaniu, Mpho Malima, Sarah Booth, Andrew G. Nicholson, Nadia Fernandes, Jessica E. Wallen & Pratibha Shah * Sheffield


Teaching Hospitals NHS Foundation Trust, Sheffield, UK Sarah Danson, Jonathan Bury, John Edwards, Jennifer Hill, Sue Matthews, Yota Kitsanta, Jagan Rao, Sara Tenconi, Laura Socci, Kim


Suvarna, Faith Kibutu, Patricia Fisher, Robin Young, Joann Barker, Fiona Taylor & Kirsty Lloyd * The Princess Alexandra Hospital NHS Trust, Harlow, UK Teresa Light, Tracey Horey, 


Dionysis Papadatos-Pastos & Peter Russell * The Whittington Hospital NHS Trust, London, UK Sara Lock & Kayleigh Gilbert * University College London Hospitals, London, UK David


Lawrence, Martin Hayward, Nikolaos Panagiotopoulos, Robert George, Davide Patrini, Mary Falzon, Elaine Borg, Reena Khiroya, Asia Ahmed, Magali Taylor, Junaid Choudhary, Penny Shaw, Sam M.


Janes, Martin Forster, Tanya Ahmad, Siow Ming Lee, Javier Herrero, Dawn Carnell, Ruheena Mendes, Jeremy George, Neal Navani, Dionysis Papadatos-Pastos, Marco Scarci, Elisa Bertoja, Robert C.


M. Stephens, Emilie Martinoni Hoogenboom, James W. Holding & Steve Bandula * University Hospital Birmingham NHS Foundation Trust, Birmingham, UK Babu Naidu, Gerald Langman, Andrew


Robinson, Hollie Bancroft, Amy Kerr, Salma Kadiri, Charlotte Ferris, Gary Middleton, Madava Djearaman & Akshay Patel * University Hospital Southampton NHS Foundation Trust, Southampton,


UK Christian Ottensmeier, Serena Chee, Benjamin Johnson, Aiman Alzetani & Emily Shaw * Velindre Cancer Centre, Cardiff, UK Jason Lester Authors * Francesca Chemi View author publications


You can also search for this author inPubMed Google Scholar * Dominic G. Rothwell View author publications You can also search for this author inPubMed Google Scholar * Nicholas McGranahan


View author publications You can also search for this author inPubMed Google Scholar * Sakshi Gulati View author publications You can also search for this author inPubMed Google Scholar *


Chris Abbosh View author publications You can also search for this author inPubMed Google Scholar * Simon P. Pearce View author publications You can also search for this author inPubMed 


Google Scholar * Cong Zhou View author publications You can also search for this author inPubMed Google Scholar * Gareth A. Wilson View author publications You can also search for this


author inPubMed Google Scholar * Mariam Jamal-Hanjani View author publications You can also search for this author inPubMed Google Scholar * Nicolai Birkbak View author publications You can


also search for this author inPubMed Google Scholar * Jackie Pierce View author publications You can also search for this author inPubMed Google Scholar * Chang Sik Kim View author


publications You can also search for this author inPubMed Google Scholar * Saba Ferdous View author publications You can also search for this author inPubMed Google Scholar * Deborah J. Burt


View author publications You can also search for this author inPubMed Google Scholar * Daniel Slane-Tan View author publications You can also search for this author inPubMed Google Scholar


* Fabio Gomes View author publications You can also search for this author inPubMed Google Scholar * David Moore View author publications You can also search for this author inPubMed Google


Scholar * Rajesh Shah View author publications You can also search for this author inPubMed Google Scholar * Maise Al Bakir View author publications You can also search for this author


inPubMed Google Scholar * Crispin Hiley View author publications You can also search for this author inPubMed Google Scholar * Selvaraju Veeriah View author publications You can also search


for this author inPubMed Google Scholar * Yvonne Summers View author publications You can also search for this author inPubMed Google Scholar * Philip Crosbie View author publications You


can also search for this author inPubMed Google Scholar * Sophia Ward View author publications You can also search for this author inPubMed Google Scholar * Barbara Mesquita View author


publications You can also search for this author inPubMed Google Scholar * Marek Dynowski View author publications You can also search for this author inPubMed Google Scholar * Dhruva Biswas


View author publications You can also search for this author inPubMed Google Scholar * Jonathan Tugwood View author publications You can also search for this author inPubMed Google Scholar


* Fiona Blackhall View author publications You can also search for this author inPubMed Google Scholar * Crispin Miller View author publications You can also search for this author inPubMed 


Google Scholar * Allan Hackshaw View author publications You can also search for this author inPubMed Google Scholar * Ged Brady View author publications You can also search for this author


inPubMed Google Scholar * Charles Swanton View author publications You can also search for this author inPubMed Google Scholar * Caroline Dive View author publications You can also search


for this author inPubMed Google Scholar CONSORTIA TRACERX CONSORTIUM * Charles Swanton * , Mariam Jamal-Hanjani * , Jonathan Tugwood * , Jackie Pierce * , Dominic G. Rothwell * , Caroline


Dive * , Ged Brady * , Francesca Chemi * , Fabio Gomes * , Fiona Blackhall * , Philip Crosbie * , Crispin Hiley * , Nicholas McGranahan * , Allan Hackshaw * , Chris Abbosh * , Selvaraju


Veeriah * , David Moore * , Gareth A. Wilson * , Nicolai Birkbak * , Sophia Ward * , Maise Al Bakir * , Dhruva Biswas * , Rajesh Shah * , Yvonne Summers * , Yenting Ngai * , Abigail Sharp *


, Cristina Rodrigues * , Oliver Pressey * , Sean Smith * , Nicole Gower * , Harjot Dhanda * , Elaine Kilgour * , Lynsey Priest * , Matthew G. Krebs * , Mathew Carter * , Colin R. Lindsay * ,


 Thomas B. K. Watkins * , Rachel Rosenthal * , Mickael Escudero * , Aengus Stewart * , Andrew Rowan * , Jacki Goldman * , Peter Van Loo * , Richard Kevin Stone * , Tamara Denner * , Emma Nye


* , Emilia Lim * , Stefan Boeing * , Maria Greco * , Kevin Litchfield * , Jerome Nicod * , Clare Puttick * , Katey Enfield * , Emma Colliver * , Brittany Campbell * , Yin Wu * , Marcin


Skrzypski * , Robert E. Hynds * , Andrew Georgiou * , Mariana Werner Sunderland * , James L. Reading * , Sergio A. Quezada * , Karl S. Peggs * , Teresa Marafioti * , John A. Hartley * , Pat


Gorman * , Helen L. Lowe * , Leah Ensell * , Victoria Spanswick * , Angeliki Karamani * , Maryam Razaq * , Stephan Beck * , Ariana Huebner * , Michelle Dietzen * , Cristina


Naceur-Lombardelli * , Mita Afroza Akther * , Haoran Zhai * , Nnennaya Kannu * , Elizabeth Manzano * , Supreet Kaur Bola * , Ehsan Ghorani * , Marc Robert de Massy * , Elena Hoxha * , Emine


Hatipoglu * , Stephanie Ogwuru * , Benny Chain * , Raffaele Califano * , Paul Taylor * , Piotr Krysiak * , Kendadai Rammohan * , Eustace Fontaine * , Richard Booton * , Matthew Evison * , 


Stuart Moss * , Juliette Novasio * , Leena Joseph * , Paul Bishop * , Anshuman Chaturvedi * , Helen Doran * , Felice Granato * , Vijay Joshi * , Elaine Smith * , Angeles Montero * , Gillian


Price * , Sylvie Dubois-Marshall * , Keith Kerr * , Shirley Palmer * , Heather Cheyne * , Joy Miller * , Keith Buchan * , Mahendran Chetty * , Mohammed Khalil * , Veni Ezhil * , Vineet


Prakash * , Girija Anand * , Sajid Khan * , Kelvin Lau * , Michael Sheaff * , Peter Schmid * , Louise Lim * , John Conibear * , Roland Schwarz * , John Le Quesne * , Joan Riley * , Lindsay


Primrose * , Luke Martinson * , Nicolas Carey * , Jacqui A. Shaw * , Dean Fennell * , Apostolos Nakas * , Sridhar Rathinam * , Louise Nelson * , Kim Ryanna * , Mohamad Tuffail * , Amrita


Bajaj * , Jan Brozik * , Fiona Morgan * , Malgorzata Kornaszewska * , Richard Attanoos * , Haydn Adams * , Helen Davies * , Zoltan Szallasi * , Roberto Salgado * , Istvan Csabai * , Miklos


Diossy * , Hugo Aerts * , Alan Kirk * , Mo Asif * , John Butler * , Rocco Bilanca * , Nikos Kostoulas * , Mairead MacKenzie * , Maggie Wilcox * , Sara Busacca * , Alan Dawson * , Mark R.


Lovett * , Michael Shackcloth * , Sarah Feeney * , Julius Asante-Siaw * , John Gosney * , Angela Leek * , Nicola Totten * , Jack Davies Hodgkinson * , Rachael Waddington * , Jane Rogan * , 


Katrina Moore * , William Monteiro * , Hilary Marshall * , Kevin G. Blyth * , Craig Dick * , Andrew Kidd * , Eric Lim * , Paulo De Sousa * , Simon Jordan * , Alexandra Rice * , Hilgardt


Raubenheimer * , Harshil Bhayani * , Morag Hamilton * , Lyn Ambrose * , Anand Devaraj * , Hema Chavan * , Sofina Begum * , Aleksander Mani * , Daniel Kaniu * , Mpho Malima * , Sarah Booth *


, Andrew G. Nicholson * , Nadia Fernandes * , Jessica E. Wallen * , Pratibha Shah * , Sarah Danson * , Jonathan Bury * , John Edwards * , Jennifer Hill * , Sue Matthews * , Yota Kitsanta * ,


 Jagan Rao * , Sara Tenconi * , Laura Socci * , Kim Suvarna * , Faith Kibutu * , Patricia Fisher * , Robin Young * , Joann Barker * , Fiona Taylor * , Kirsty Lloyd * , Teresa Light * , 


Tracey Horey * , Dionysis Papadatos-Pastos * , Peter Russell * , Sara Lock * , Kayleigh Gilbert * , David Lawrence * , Martin Hayward * , Nikolaos Panagiotopoulos * , Robert George * , 


Davide Patrini * , Mary Falzon * , Elaine Borg * , Reena Khiroya * , Asia Ahmed * , Magali Taylor * , Junaid Choudhary * , Penny Shaw * , Sam M. Janes * , Martin Forster * , Tanya Ahmad * , 


Siow Ming Lee * , Javier Herrero * , Dawn Carnell * , Ruheena Mendes * , Jeremy George * , Neal Navani * , Dionysis Papadatos-Pastos * , Marco Scarci * , Elisa Bertoja * , Robert C. M.


Stephens * , Emilie Martinoni Hoogenboom * , James W. Holding * , Steve Bandula * , Babu Naidu * , Gerald Langman * , Andrew Robinson * , Hollie Bancroft * , Amy Kerr * , Salma Kadiri * , 


Charlotte Ferris * , Gary Middleton * , Madava Djearaman * , Akshay Patel * , Christian Ottensmeier * , Serena Chee * , Benjamin Johnson * , Aiman Alzetani * , Emily Shaw *  & Jason


Lester CONTRIBUTIONS C.S., C.D., P.C., D.G.R. and G.B. developed the clinical study, directed research and co-wrote the manuscript. F.C. designed and conducted experiments, analyzed data and


drafted the manuscript with the assistance of D.G.R. and N.M.G. S.G., S.P.P., G.W., N.B., N.M.G., C.S.K., S.F., C.M. and M.D. provided bioinformatic support for the study. C.A. provided


support for the clinical interpretation of the data. C.Z. performed statistical analysis. C.A. and D.M. performed central pathology review. D.B., D.S.T. and B.M. provided support for


single-cell isolation. M.J.-H., J.P., F.G., R.S., M.A.B., C.H., S.V., Y.S., P.C., S.W., D.B., J.T., F.B. and A.H. supported patient recruitment and sample management and provided clinical


support for the study. CORRESPONDING AUTHORS Correspondence to Ged Brady, Charles Swanton or Caroline Dive. ETHICS DECLARATIONS COMPETING INTERESTS C.D. receives research grants/support from


AstraZeneca, Astex Pharmaceuticals, Bioven, Amgen, Carrick Therapeutics, Merck, Taiho Oncology, GSK, Bayer, Boehringer Ingelheim, Roche, BMS, Novartis, Celgene and Epigene Therapeutics,


Menarini, Angle PLC and Clearbridge Biomedics, all of which are outside the scope of this paper. C.D. has received honoraria/consultancy fees from Biocartis, Merck and AstraZeneca and


Illumina, again outside the scope of this work. C.S. receives grant support from Pfizer, AstraZeneca, BMS and Roche-Ventana, Boehringer-Ingelheim. C.S. has consulted for Pfizer, Novartis,


GlaxoSmithKline, MSD, BMS, Celgene, AstraZeneca, Illumina, Genentech, Roche-Ventana, GRAIL, Medicxi and the Sarah Cannon Research Institute and is an adviser for Dynamo Therapeutics. C.S. is


a shareholder of Apogen Biotechnologies, Epic Bioscience and GRAIL, and has stock options in and is cofounder of Achilles Therapeutics. ADDITIONAL INFORMATION PEER REVIEW INFORMATION Joao


Monteiro was the primary editor on this article and managed its editorial process and peer review in collaboration with the rest of the editorial team. PUBLISHER’S NOTE Springer Nature


remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. EXTENDED DATA EXTENDED DATA FIG. 1 PV-CTCS ARE ASSOCIATED WITH LUNG-CANCER-SPECIFIC


RELAPSE. A, tdROC curves showing true-positive and false-positive rates for the 65th, 75th and 85th PV-CTC quantiles (≥3, ≥7, and ≥39 PV-CTCs per 7.5 ml blood, respectively) alongside the


previously published threshold from our pilot study (≥18 PV-CTCs per 7.5 ml blood)11. All predictions were made at 720 d. Sensitivity and specificity of each category are shown along with


area under ROC value. B, Kaplan–Meier curve showing lung-cancer-specific relapse-free survival for 98 patients stratified as PV-CTC high or low according to the 75th quantile (≥7 PV-CTCs per


7.5 ml blood). The number of patients at risk for each time point is indicated below the time point and color coded according to the high or low group. _P_ values, HRs and relative 95% CIs


(two-sided log-rank test) are indicated. C, Forest plot showing the results of multivariate regression analysis for patients with PV-CTC high or low status (≥7 PV-CTCs per 7.5 ml blood). The


_x_-axis represents the HR with the reference line (dashed), and significance was calculated using a Cox proportional hazards model. The estimated HRs and their 95% CIs are presented as


error bars. The log-rank test used was two sided. EXTENDED DATA FIG. 2 TECHNICAL DETAILS OF SINGLE-CELL ANALYSIS OF PATIENT CRUK0242. A, Consort diagram describing samples used for


downstream analysis. Only patients with ≥5 PV-CTCs (_n_ = 29) were processed through single-cell isolation (DEPArray). Single cells were not isolated from 6 of the 29 samples owing to


failures during sample loading into the DEPArray machine. From the remaining 23 samples, 7 patients whose single CTCs isolated did not meet morphology criteria (Methods) were excluded.


Sixteen samples were processed for WGA, and two patients whose CTCs did not show good quality GII in quality control after WGA were removed (Methods). B, Table showing cases of relapse in


the patients with single PV-CTCs isolated. C, Agarose gel showing results of a quality-control PCR assay used to determine the genome integrity of each sample (_n_ = 1). 0–4 bands determine


the overall DNA integrity of each sample. DEPArray images of corresponding PV-CTC (green, cytokeratin; blue, CD45; purple, DAPI) are shown above. D, Examples of copy number profiles detected


in single PV-CTCs, CECs, and WBC controls. Blue and red indicate regions of copy number loss and gain, respectively. EXTENDED DATA FIG. 3 GENETIC RELATIONSHIP BETWEEN PV-CTCS, PRIMARY TUMOR


AND METASTATIC DISEASE. A, Venn diagram showing the overlap of somatic mutations detected among single PV-CTCs, primary tumor and metastatic tumor. B, Venn diagram showing the overlap of


somatic mutations detected among single PV-CTCs, metastatic tumor and cfDNA isolated at the time of relapse. EXTENDED DATA FIG. 4 SUMMARY OF ALL MUTATIONS DETECTED IN PATIENT CRUK0242. Heat


map showing the comparison of SNVs detected in primary tumor regions, metastasis, PV-CTCs, CECs, WBCs and cfDNA samples (cfDNA before surgery was isolated from peripheral blood; cfDNA


surgery was isolated from the pulmonary vein; and cfDNA relapse was isolated at the time of relapse). Mutations are ordered according to their clonality established by primary tumor


analysis. SUPPLEMENTARY INFORMATION REPORTING SUMMARY SUPPLEMENTARY TABLES 1–12 Supplementary Tables 1-12 RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE


Chemi, F., Rothwell, D.G., McGranahan, N. _et al._ Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse. _Nat Med_ 25, 1534–1539 (2019).


https://doi.org/10.1038/s41591-019-0593-1 Download citation * Received: 09 July 2019 * Accepted: 20 August 2019 * Published: 07 October 2019 * Issue Date: October 2019 * DOI:


https://doi.org/10.1038/s41591-019-0593-1 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not


currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative